ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 183 filers reported holding ARCUS BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $27,929,551 | -22.7% | 1,833,851 | -4.2% | 0.07% | -17.0% |
| Q1 2024 | $36,153,916 | +146.2% | 1,914,932 | +149.1% | 0.09% | +144.4% |
| Q4 2023 | $14,683,125 | +18253.2% | 768,750 | +17148.1% | 0.04% | – |
| Q3 2023 | $80,003 | -99.4% | 4,457 | -99.4% | 0.00% | -100.0% |
| Q2 2023 | $14,412,809 | +63.9% | 709,641 | +66.9% | 0.04% | +43.3% |
| Q4 2022 | $8,795,225 | +481.3% | 425,301 | +635.4% | 0.03% | +400.0% |
| Q3 2022 | $1,513,000 | -14.4% | 57,834 | -8.1% | 0.01% | -25.0% |
| Q1 2021 | $1,767,000 | -46.9% | 62,926 | -67.6% | 0.01% | -52.9% |
| Q3 2020 | $3,325,000 | – | 194,001 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,842,077 | $64,233,000 | 17.21% |
| Octagon Capital Advisors LP | 970,164 | $33,830,000 | 8.33% |
| Copernicus Capital Management, LLC | 17,000 | $593,000 | 7.18% |
| EcoR1 Capital, LLC | 5,122,359 | $178,617,000 | 6.21% |
| BVF INC/IL | 3,229,822 | $112,624,000 | 4.39% |
| PFM Health Sciences, LP | 3,431,010 | $119,639,000 | 3.52% |
| Alphabet Inc. | 4,100,475 | $142,984,000 | 3.39% |
| Boxer Capital, LLC | 2,084,883 | $72,700,000 | 2.54% |
| SECTORAL ASSET MANAGEMENT INC | 739,010 | $25,769,000 | 2.14% |
| Parkman Healthcare Partners LLC | 236,637 | $8,252,000 | 2.09% |